Home » Tenders » Americas » USA » Tender 131431469

Battlefield Wound Infection Prevention Tender in USA - 131431469

The ITY-RESULT _NGCONTENT-NG-C3280571707="" _NGHOST-NG-C893956049="" CLASS="NG-STAR-INSERTED" BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT has issued a Tender notice for the procurement of a Battlefield Wound Infection Prevention and Treatment Bwi Pt Barrier Combination Product Development in the USA. This Tender notice was published on 04 Dec 2025 and is scheduled to close on 20 Jan 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 131431469, while the tender notice number is HT9427-26-RFI-BWI-PT and Registering on the platform.

Procurement Summary

Country: USA

Summary: Battlefield Wound Infection Prevention and Treatment Bwi Pt Barrier Combination Product Development

Deadline: 20 Jan 2026

Posting Date: 04 Dec 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 131431469

Document Ref. No.: HT9427-26-RFI-BWI-PT

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

The Government is conducting market research to determine whether a commercial solution can be provided to meet requirements for battlefield wound infection prevention and treatment: barrier combination product. This market research may also assist with the further development and/or refinement of the requirements.
Objective and Purpose/Scope: DHA-s OPMED WPAC has a requirement to develop, deliver, and field medical products that address battlefield wounds and subsequent bacterial and fungal infections. The Battlefield Wound Infection Prevention and Treatment (BWI P&T) program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products may be limited and evacuation may be prolonged.
This RFI seeks responses to the barrier combination component of this FoS only.
Although there is an emphasis on use at the point of injury, this capability will likely be used across roles
of care spanning the austere battlefield environment to hospital care settings. The barrier combination product is
expected to be one of many components of the FoS that will provide novel solutions to the DoD and commercial
market with respect to wound care and infection prevention.
The barrier combination product must have the following minimum essential characteristics:
Please refer to Attachment 3 - Minimum Essential Characteristics (MECS)
North American Industry Classification System (NAICS) Code: Unknown
RFI Attachments: The following documents are attached to the RFI
Attachment 1: Technical Readiness Level (TRL) (Reference Only)
Attachment 2: Company & Product Information
Attachment 3: Minimum Essential Characteristics (MECS)
Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm Eastern on January 20, 2026, via e-mail to:
Please review Attachments 1, 2, and 3 as well as RFI for BWI PT Barri...
Notice ID: ht9427-26-rfi-bwi-pt

Department/Ind. Agency: dept of defense

Sub-tier: defense health agency (dha)

Office: defense health agency

Inactive Dates: feb 04, 2026

Inactive Policy: 15 days after response date

Documents

Tender Notice

Browse More

All Tenders From USA

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By